Analysis & Opinions
July 02, 2012
The market is currently down, with the Nasdaq falling 0.2%, the S&P 500 down 0.2% and the Dow decreasing 0.5%. The ...
June 19, 2012
We have maintained our Neutral recommendation on Theravance, Inc. (THRX) with a target price of $20.00 per share. ...
June 13, 2012
GlaxoSmithKline (GSK) recently announced that its subsidiary, Stiefel, has entered into an agreement with Basilea ...
March 19, 2012
Some value investors stay out of the spotlight. Seth Klarman is one of those under-the-radar names.
December 08, 2009
It's always a good idea to watch the pros, especially guys like Seth Klarman.